QLT Publishes Data From Phase 1b Trial Of QLT091001 In Subjects With Leber Congenital Amaurosis In The Lancet Journal

By: via Benzinga
QLT Inc. (Nasdaq: QLTI) (TSX:QLT) ("QLT" or the "Company") today announced the publication of data from its Phase 1b proof-of-concept ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.